INV-202

About Indivior PLC

Indivior is a mission-driven, publicly traded biopharmaceutical company dedicated to saving lives from the devastating impacts of substance use disorders and mental illness. Its strategic foundation is built upon a 25-year legacy of innovation in buprenorphine-based medication-assisted treatment (MAT), most notably through the commercialization of SUBLOCADE®, a once-monthly injectable that has become the standard of care. Following a strategic redomiciliation to the U.S. and resolution of legacy legal matters, the company is now executing a focused growth strategy to defend its core OUD franchise while advancing a promising pipeline targeting schizophrenia and cocaine use disorder.

Therapeutic Areas